Abstract
Many pharmaceutical pollutants are chiral, existing in the environment as a single enantiomer or as mixtures of the two enantiomers. In spite of their similar physical and chemical properties, the different spatial configurations lead the enantiomers to have different interactions with enzymes, receptors or other chiral molecules, which can give diverse biological response. Consequently, biodegradation process and ecotoxicity tend to be enantioselective. Despite numerous ongoing research regarding analysis and monitorization of pharmaceutical ingredients in the environment, the fate and effects of single enantiomers of chiral pharmaceuticals (CP) in the environment are still largely unknown. There are only few chiral analytical methods to accurately measure the enantiomeric fraction (EF) in environmental matrices and during biodegradation processes. Furthermore, the ecotoxicity studies usually consider the enantiomeric pair as unique compound. We reviewed the current knowledge about CP in the environment, as well as the chiral analytical methods to determine the EF in environmental matrices. The degradation and removal processes of CP of important therapeutic classes, usually detected in the environment, and their toxicity to aquatic organisms were also reviewed. On the other hand, this review demonstrate that despite the great importance of the stereochemistry in pharmaceutical science, pharmacology and organic chemistry, this is normally neglected in environmental studies. Therefore, CP in the environment need much more attention from the scientific community, and more research within this subject is required.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
This manuscript is an abridged version of our chapter published in the book Environmental Chemistry for a Sustainable World (Ribeiro et al. 2012). Chiral compounds are substances with a similar chemical structure that, in general, confers them the same physical and chemical properties like melting point, solubility and reactivity. However, they differ in the deviation of polarized light due to the different spatial configuration, originated by planes, axis or centers of asymmetry, given two non-superposable left-handed and right-handed mirror images compounds, called enantiomers. In the case of enantiomers with asymmetric center, the most common examples are those with a carbon holding a set of four different substituents in a spatial arrangement generating a stereogenic center (Fig. 1), but other atoms such as sulfur or phosphorus can also be a stereogenic center (Fig. 2).
Despite the similar thermodynamic properties in achiral medium, enantiomers normally have a different behaviour when the environment is also chiral. Amino acids, carbohydrates, deoxyribose and ribose are chiral compounds that are the unity of important natural molecules such as proteins, glycoproteins, DNA and RNA, respectively (Müller and Kohler 2004; Hühnerfuss and Shah 2009). As such, in biological processes, enzymes, receptors and other binding-molecules have the capacity to recognize enantiomers in a different way. Therefore, enantiomers of chiral pharmaceuticals (CP) can present different pharmacokinetic and pharmacodynamic properties, different dissociation constant from the binding site and different attachment to it (Fig. 3), leading to different biological response in quality or quantity (Campo et al. 2009).
There are many CP that need to be commercialized as a single enantiomer, mostly due to the association of the enantiomers to different receptors, leading to different responses (Mannschreck et al. 2007). However, there are many CP that are both commercialized as racemic and enantiopure forms (Tucker 2000; Hutt and Valentová 2003; Orlando et al. 2007). Table 1 shows some CP that can be used as racemates and/or enantiopure formulations, depending on the effects of each enantiomer (Lima 1997).
The recent advances in stereoselective synthesis and chiral analysis led to an increase in the single enantiomers as drugs available in the market (Hutt 1998). The re-evaluation of the license of the enantiomeric pure drugs that were produced as a racemic mixture, called as chiral switching process, also contributed to increase the use of single enantiomers (Cordato et al. 2003; Hutt and Valentová 2003; Caner et al. 2004).
There are also some CP, such as propionic acid derivatives belonging to non-steroid anti-inflammatory drugs (NSAIDs), which suffer chiral inversion, and yet are commercialized as racemates in most countries, except naproxen (Fig. 4). Ibuprofen (IB) (Fig. 5) is a common example of NSAIDs, which is normally sold as racemate, although S-(+)-IB is practically responsible for the pharmacologic action. Moreover, this drug, as other profens, suffers unidirectional conversion in vivo to the pharmacologic active S-(+)-IB, which makes more difficult to obtain the enantiopure S-(+)-IB with a good percentage of conversion, justifying the use of racemates (Lima 1997; Tucker 2000; Carvalho et al. 2006).
Another therapeutic option is the use of CP with an enantiomeric ratio different from 1 to improve the benefits of each enantiomer, when applicable. Enantiomeric fraction (EF) is the proportion of the concentration of one enantiomer to the total concentration, expressing the relative concentration of an enantiomer’s compound. Racemate exhibits an EF of 0.5 while an enantiomerically pure compound has a value of 0 or 1. As an example, the advantage of the administration of a mixture of S0.75/R0.25 bupivacaíne rather than the racemate was reported, with the same anesthetic properties and with less toxicity (Gonçalves et al. 2003).
This review emphasizes three pharmaceutical classes: Beta-blockers, Antidepressants and NSAIDs, due to their persistence in the environment and respective ecological effects (Ternes 1998; Trenholm et al. 2006; Vanderford and Snyder 2006; Pérez and Barceló 2008; Fernández et al. 2010; Santos et al. 2010).
Analytical methods for quantification/identification of chiral pharmaceuticals in the environment
Gas chromatography
Gas chromatography (GC) have the advantages of high efficiency, sensitivity and speed of separation, ability to separate analytes from impurities and not needing optimization of mobile phase concerning solvents, pH, modifiers and gradients (Eljarrat et al. 2008). The indirect mode resulting in diastereoisomers separation can be easily applied (Bojarski 2002; Carvalho et al. 2006; Hühnerfuss and Shah 2009) while the direct mode with a chiral stationary phase (CSP) is limited to only a few commercial CSP available. The most used columns are cyclodextrin-based and have demonstrated a great applicability in organochlorine pesticides (Wong and Garrison 2000; Eljarrat et al. 2008). Another useful CSP is based on metal complexes such as metal-β-diketonate polymers (Rykowska and Wasiak 2009).
The disadvantages of GC are the need of derivatization, in some cases, to increase the volatility, to prevent the peak tailing and thus to improve detection limits by the peak shaping (Zhang et al. 2009). The high temperature used can also lead to racemization or decomposition (Schurig 2001; Jiang and Schurig 2008). Thus, GC has several limitations to environmental analyses of CP (Huggett et al. 2003; Lamas et al. 2004; Jones et al. 2007).
High performance liquid chromatography (HPLC)–Liquid chromatography/mass spectrometry (LC–MS/MS)
High performance liquid chromatography (HPLC) has become a technique of routine analysis because of the numerous combinations of the available columns with a high diversity of mobile phases, and the detection methods that can be coupled, such as ultra-violet (UV), fluorescence (FD) and mass spectrometry (MS) (Aboul-Enein and Ali 2004; Görög 2007). Direct methods using CSP are usually the first choice for analysis of CP by HPLC. There are many different types of commercial chiral columns for HPLC: Pirkle type or donor-acceptor CSP, crown ethers CSP, ligand-exchange CSP, polysaccharide derivatives CSP, cyclodextrin CSP, protein CSP, macrocyclic glycopeptides antibiotics CSP and others such as CSP based on synthetic polymers (Pirkle and Pochapsky 1989; Haginaka 2008; Lämmerhofer 2010). The major advantage of this method is the ability of the analyte to remain unmodified. The choice of the CSP is based on the experience and the available literature, being often empirical by trial and error evaluation. However, some authors start with polysaccharides or macrocyclic antibiotics because of their broad application and the possibility to operate in normal, reverse phase, polar organic mode and polar ionic mode (Perrin et al. 2002a, b; Andersson et al. 2003; Cass et al. 2003; Sousa et al. 2004; Ates et al. 2008; Pirzada et al. 2010). The most frequent separation mode is normal phase; however, this tendency is turning to reverse phase, polar organic mode and polar ionic mode, being all applicable to the most used polysaccharides or macrocyclic antibiotics CSPs (Cass and Batigalhia 2003; Cass et al. 2003; Montanari et al. 2006; Hashem et al. 2011).
Molecularly imprinted polymers (MIP) are a synthetic alternative in which the target compound is used in the polymerization process as a template, to produce a specific receptor to one enantiomer which is known to be more retained. The removal of the template by a solvent or a chemical reaction provides a complementary site in the receptor to the target molecule, providing a MIP which can be used as CSP and incorporated in conventional HPLC columns. These materials are easy to obtain, highly selective and stable, and the elution order is predictable. The drawback of MIP is the peak tailing produced due to the heterogeneous binding site (Wistuba and Schurig 2000; Sancho and Minguillón 2009).
The high variety of chiral commercial columns usually designed for HPLC analysis and the different elution modes makes this technique a powerful tool for chiral analysis (Perrin et al. 2002a, b; Andersson et al. 2003; Zhang et al. 2010). HPLC with different type of detection has been used for the determination of the EF of many CP in a variety of matrix, including environmental samples (Francotte 2009; Kasprzyk-Hordern et al. 2010). Few examples of analyses of environmental matrices are shown in Table 2.
Liquid chromatography/mass spectrometry (LC–MS/MS) have played a crucial role in environmental analysis (Niessen 2003; Kot-Wasik et al. 2007; Pérez and Barceló 2007; Pérez and Barceló 2008) mainly due to their versatility, sensitivity and selectivity (González et al. 2007). Recent trends in environmental mass spectrometry methods have been emerging with special focus on hybrid mass spectrometers such as quadrupole-time of flight (Qq-TOF) (Farré et al. 2008) and quadrupole-linear ion trap (Qq-LIT) (Díaz-Cruz et al. 2008). However, triple quadrupole (QqQ) mass analyzers are the most used analytical technology in environmental analyses (Gros et al. 2006; Nikolai et al. 2006; MacLeod et al. 2007; Kasprzyk-Hordern et al. 2010; MacLeod and Wong 2010; Barclay et al. 2011; Li et al. 2011). Few publications have also employed ion trap (IT) mass spectrometers for environmental determinations (Feitosa-Felizzola et al. 2007; Madureira et al. 2009; Barreiro et al. 2010, 2011).
Other techniques
Capillary electro-chromatography (CEC) is a hybrid technique of HPLC and capillary electrophoresis (CE). Likewise HPLC has high selectivity because of the wide range of mobile and stationary phases available. Likewise CE, it has high peak efficiency without the necessity of high pression (Sancho and Minguillón 2009). It is thus an easy technique with a short time of analysis and a low consumption of sample and electrolyte, providing a high potential in pharmaceutical, biomedical and environmental analysis (Li et al. 2010). The chiral selectors used in CEC include crown ethers, cyclodextrins, polysaccharides, proteins and macrocyclic glycopeptides antibiotics, the same selectors used in HPLC (Scriba 2003).
Micellar electrokinetic capillary chromatography (MEKC) is a technique that consists in the addition of a surfactant molecule (above its critical micellar concentration) in CE, leading to the formation of a micellar pseudo-stationary phase in solution, occurring partition mechanisms between the micellar pseudo-stationary phase and the mobile phase. Enantioresolution can be achieved using chiral surfactants or using chiral agents that are added to an achiral micellar buffer, such as combination of micelles and cyclodextrins or modified cyclodextrins, or both of them to improve the enantioresolution. A recent approach is the use of polymeric surfactants, a group of high-molecular-mass molecules that allows slower mass transfer of the analytes between the pseudo-stationary phase and the mobile phase, leading to a lower resolution compared to the conventional micelles (Hernández-Borges et al. 2005; Ha et al. 2006).
Super critical fluid chromatography (SFC) is a hybrid technique of GC and LC and has the advantages of providing higher flow rates and faster separation than LC and a lower dispersion because of the equal density, dissolving capacity, the intermediate viscosity and diffusion coefficient of its mobile phase, which is compared with those used in GC and HPLC due to the ability to carry compounds and to dissolve them, respectively (Taylor 2009). This technique is an alternative to HPLC when the enantioresolution is partial by normal phase or is not achieved by reverse phase, providing a lower consumption of solvents and the use of non-toxic and non-explosive solvents. However, there are some limitations like high cost of the equipment, complexity of the hardware and the weak experience available in this technique (Maftouh et al. 2005).
Thin layer chromatography (TLC) is preferentially used in indirect mode but it is limited because of its low resolution and weak ability to detect concentrations as low as those found in the environment. TLC can be used as complementary to HPLC since it is less expensive and allows the optimization of the separation parameters in less time and with less costs (Bhushan and Martens 1997), however, the application on environmental analysis is very limited.
Electrochemical Sensors and Biosensors provide an enantioselective analysis using an electrochemical cell coupled to a chiral receptor (potentiometric enantioselective membrane electrodes, PEME), an enzyme (chiral amperometric biosensors) or an antibody (enantioselective immunosensors), in which the sample flows without separation steps, providing direct determination in the matrix, high precision, fastness and the possibility of on-line detection with flow injection analysis and sequential injection analysis systems (Izake 2007). The principle of PEME is based on the thermodynamics of the reaction between each enantiomer and the chiral selector, with different stability in the complexes formed, leading to different reaction energies (Izake 2007).
Biotic and abiotic degradation and removal processes of chiral pharmaceuticals (CP) in the environment
Removal of pharmaceuticals in surface waters can be due to photo-transformation, biodegradation, hydrolysis and partition to sediment (Liu et al. 2009) while their removal in waste water treatment plants (WWTP) is mostly restricted to biodegradation and to abiotic processes such as oxidation and sorption. Recently, Patrick et al. (2011) reported the stereoselective microbial-assisted incorporation of organic substances into soil organo-clay complexes to form non-extractable residues. They highlighted the need to consider the formation of bound residues in environmental studies dealing with stereoselective analysis of organic pollutants in soils to study their microbial transformation (Patrick et al. 2011).
The comparison of conventional activated sludge systems and membrane bioreactors to remove CP from wastewaters was reviewed (Sipma et al. 2010). This study included racemates of CP like beta-blockers (atenolol, metoprolol, propranolol), antidepressants (fluoxetine, paroxetine) and NSAIDs (IB, indomethacin, ketoprofen, mefenamic acid, naproxen, propyphenazone).
There are many studies on microbial degradation of CP in the environment as racemates (Trautwein et al. 2008; Benotti and Brownawell 2009; Calisto and Esteves 2009; Mascolo et al. 2010; Santos et al. 2010). However, biodegradation studies of individual enantiomers are scarcer—few examples are related on Table 3 (Buser et al. 1999; Winkler et al. 2001; Fono and Sedlak 2005; Fono et al. 2006; Matamoros et al. 2009).
Biodegradation needs attention concerning the enantiomeric degradation ratio, since microorganisms can degrade selectively one enantiomer, can alter their enantioselective activity, can promote the enantiomerization and can also degrade both enantiomers at the same extent ratio, which is more unlikely to happen (Pérez and Barceló 2008).
Propranolol (PHO), a beta-blocker used for treatment of cardiovascular diseases, with annual sales of the brand Inderal® of about $30 billion (Bartholow 2010), is normally detected in surface waters and WWTP effluents (Ternes 1998; Huggett et al. 2003; Fono and Sedlak 2005). PHO is an important tool to distinguish the raw and treated sewage since PHO has an EF of 0.5 (racemic) in WWTP’s influent and significantly below 0.5 in WWTP’s effluent, suggesting that this CP is degraded enantioselectively through the biological treatment (Fono and Sedlak 2005). In the same study, EF decreased in microcosms inoculated with activated sludge but remain constant in not-inoculated or sterilized treatments. The same researchers found in microcosms experiments that the EF of metoprolol (MET), an analogous beta-blocker, decreased from the effluent to downstream, suggesting a enantioselective biodegradation (Fono et al. 2006).
Atenolol (ATE) is a beta-blocker also used for treatment of cardiovascular diseases with annual sales of the brand Tenormin® of approximately $102 million included in the Top 200 Prescription Drugs of 2009 of United States (Bartholow 2010). It was one of the 11 most frequently detected compounds in United States in drinking water, being classified as an indicator of endocrine disrupting compounds as well as an indicator of the treatment success of a WWTP (Benotti et al. 2009). In an enantioselective evaluation of effluents of three different WWTP in Canada, the EF of ATE was different for the different effluents, indicating that the different microbial communities can affect the enantioselectivity of the biodegradation (MacLeod and Wong 2010).
Fluoxetine (FX), an antidepressant of the group of Selective Serotonin Reuptake Inhibitors, is one of the most dispensed drugs in the world (Stanley et al. 2007) and one of the most prescribed drugs included in the Top 200 of the United States (Bartholow 2010). FX was found in surface waters, treated wastewater, raw influent and even in finished drinking water in United States and South Korea at ng L−1 levels (Trenholm et al. 2006; Vanderford and Snyder 2006). FX and also its active metabolite Nor-Fluoxetine (Nor-FX) have been detected in WWTP’s effluents and in surface waters (MacLeod et al. 2007). FX was reported as a persistent pharmaceutical after chlorine treatment rather than ozone because of the more potent oxidant effect attributed to ozone (Westerhoff et al. 2005). In a dissipation study of 5 selective serotonin reuptake inhibitors in aquatic microcosms, FX was the most persistent (Johnson et al. 2005). In a study using batch incubation of seawater samples, Benotti and Brownawell (2009) included FX in the more labile group and considered that adsorption to suspended sediment was minimal.
Ibuprofen, a NSAID used for pain, fever and rheumatism, is the third most popular clinically used drug in the world and one of the 200 drugs most prescribed in the Unites States in 2009 (Bartholow 2010). Some researchers reviewed the occurrence of IB in numerous sediment and aquatic compartments (Ali et al. 2009). Buser et al. (1999) detected IB in river, lakes and influents of WWTP, with a higher concentration of the pharmacologically active (S)-enantiomer. In the same study, the degradation behavior was similar during experiments using WWTP influent incubated with activated sludge and lake water fortified with rac-IB, with a faster dissipation of the (S)-enantiomer, mostly biological-mediated. There are other studies reporting the decrease in EF of IB, the removal in the secondary biological treatment and differences in the behavior of IB EF’s under anaerobic (similar degradation of both enantiomers) and aerobic conditions with (S)-form predominantly degraded, which are according to the biological-mediated degradation (Jones et al. 2007; Matamoros et al. 2009; Hijosa-Valsero et al. 2010). Still naproxen EF’s showed a similar pattern in degradation at both aerobic and anaerobic conditions, making it a good indicator for removal efficiency in aerobic or anaerobic wastewater treatment systems (Matamoros et al. 2009). Thus, there are very few reports concerning enantioselective degradation of CP in the environment. It is important to include this issue mostly in the biodegradation studies due to the enantioselectivity of the biological processes. Assessing the more recalcitrant enantiomers is of high importance to ecotoxicity.
Toxicity of emergent chiral pharmaceuticals (CP) in aquatic organisms
There are few studies about ecotoxicity of single enantiomers of CP to aquatic organisms (Khetan and Collins 2007). On the other hand, most are performed at concentrations higher than those found in the environment (Fent et al. 2006) as shown in the Table 4.
PHO and FX were classified as compounds with a high potential of environmental risk (Christen et al. 2010). Briefly, in a recent report, the presence of three beta adrenergic receptor subtypes (β1, β2, β3) in the fathead minnow was demonstrated, with tissue localization of these receptors similar to those observed in mammals (Giltrow et al. 2011), which can be related to the potential effects that beta-blockers can cause in aquatic ecosystems.
FX in the environment has antimicrobial properties, mainly against Gram positive bacteria. This CP has a synergic activity with some antibiotics, even when there is some resistance, or can increase the activity of them, exerting toxicity by inhibiting cellular efflux pumps (Munoz-Bellido et al. 2000). The accumulation of FX in three fish species (Lepomis macrochirus, Ictalurus punctatus, and Pomoxis nigromaculatus) was reported in brain, liver and muscle tissues at ng g−1 levels (Brooks et al. 2005). Paterson and Metcalfe (2008) studied the uptake and depuration of FX in a freshwater fish species, Japanese medaka (Oryzias latipes), and found a half-life three times higher than in mammalian species and a lower ability to biodegrade and eliminate such drug and its metabolite Nor-FX. So, FX can indicate a recalcitrant behavior in biological tissues, suggesting the possible chronic effects (Paterson and Metcalfe 2008). FX is also related with interfering with brain expression of feeding-related peptides in female goldfish (Carassius auratus), decreasing food intake and reducing weight (Mennigen et al. 2009, 2010).
The studies involving the occurrence and removal of pharmaceuticals should contemplate bioassays as the reduction in the concentrations does not demonstrate the absence of toxicity (Reungoat et al. 2010). Another important features that are not considered in almost studies are the mixture effects of CP, the transformation products and the food quality of the organisms used in toxicological tests (Flaherty and Dodson 2005; Isidori et al. 2005; Hansen et al. 2008).
Conclusions
Methods for quantification of single enantiomers of CP in the environment were reviewed, demonstrating that they are scarce. Thus, chiral analytical methods for an accurate quantification of enantiomers in the environment are imperative for a better knowledge of the environmental fate of CP. Few studies concerning the biodegradation performance and ecotoxicity of racemic mixtures and the individual enantiomers were also related, and in many cases, enantioselectivity was observed. The biodegradation and toxicity of isolated enantiomers on non-target organisms are also fields to be investigated.
References
Aboul-Enein HY, Ali I (2004) Analysis of the chiral pollutants by chromatography. Toxicol Environ Chem 86(1):1–22
Ali I, Singh P, Aboul-Enein HY, Sharma B (2009) Chiral analysis of ibuprofen residues in water and sediment. Anal Lett 42(12):1747–1760
Andersson ME, Aslan D, Clarke A, Roeraade J, Hagman G (2003) Evaluation of generic chiral liquid chromatography screens for pharmaceutical analysis. J Chromatogr A 1005(1–2):83–101
Ates H, Mangelings D, Vander Heyden Y (2008) Chiral separations in polar organic solvent chromatography: updating a screening strategy with new chlorine-containing polysaccharide-based selectors. J Chromatogr B 875(1):57–64
Barclay VKH, Tyrefors NL, Johansson IM, Pettersson CE (2011) Trace analysis of fluoxetine and its metabolite norfluoxetine. Part I: development of a chiral liquid chromatography–tandem mass spectrometry method for wastewater samples. J Chromatogr A 1218(33):5587–5596
Barreiro JC, Vanzolini KL, Madureira TV, Tiritan ME, Cass QB (2010) A column-switching method for quantification of the enantiomers of omeprazole in native matrices of waste and estuarine water samples. Talanta 82(1):384–391
Barreiro JC, Vanzolini KL, Cass QB (2011) Direct injection of native aqueous matrices by achiral-chiral chromatography ion trap mass spectrometry for simultaneous quantification of pantoprazole and lansoprazole enantiomers fractions. J Chromatogr A 1218(20):2865–2870
Bartholow M (2010) Top 200 prescription drugs of 2009. Retrieved 27 May 2010
Benotti MJ, Brownawell BJ (2009) Microbial degradation of pharmaceuticals in estuarine and coastal seawater. Environ Pollut 157(3):994–1002
Benotti MJ, Trenholm RA, Vanderford BJ, Holady JC, Stanford BD, Snyder SA (2009) Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ Sci Technol 43(3):597–603
Bhushan R, Martens J (1997) Direct resolution of enantiomers by impregnated TLC. Biomed Chromatogr 11(5):280–285
Bojarski J (2002) Stereoselective chromatography of cardiovascular drugs: an update. J Biochem Biophys Methods 54(1–3):197–220
Brooks BW, Turner PK, Stanley JK, Weston JJ, Glidewell EA, Foran CM, Slattery M, La Point TW, Huggett DB (2003) Waterborne and sediment toxicity of fluoxetine to select organisms. Chemosphere 52(1):135–142
Brooks BW, Chambliss CK, Stanley JK, Ramirez A, Banks KE, Johnson RD, Lewis RJ (2005) Determination of select antidepressants in fish from an effluent-dominated stream. Environ Toxicol Chem 24(2):464–469
Buser H-R, Poiger T, Muller MD (1999) Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ Sci Technol 33(15):2529–2535
Calisto V, Esteves VI (2009) Psychiatric pharmaceuticals in the environment. Chemosphere 77(10):1257–1274
Campo VL, Bernardes LSC, Carvalho I (2009) Stereoselectivity in drug metabolism: molecular mechanisms and analytical methods. Curr Drug Metab 10(2):188–205
Caner H, Groner E, Levy L, Agranat I (2004) Trends in the development of chiral drugs. Drug Discov Today 9(3):105–110
Carvalho PO, Cass QB, Calafatti SA, Contesini FJ, Bizaco R (2006) Review-alternatives for the separation of drug enantiomers: ibuprofen as a model compound. Braz J Chem Eng 23(3):291–300
Cass QB, Batigalhia F (2003) Enantiomeric resolution of a series of chiral sulfoxides by high-performance liquid chromatography on polysaccharide-based columns with multimodal elution. J Chromatogr A 987(1–2):445–452
Cass QB, Degani ALG, Cassiano NM (2003) Effects on enantioselectivity by the use of polysaccharide-based columns by multimodal elution. J Liq Chromatogr Relat Technol 26(13):2083–2101
Chen C-Y, Shieh W-R, Chen C-S (1992) Clinical implications of using racemic drugs. Clin Res Regul Aff 9(4):247–259
Choonara IA, Haynes BP, Cholerton S, Breckenridge AM, Park BK (1986) Enantiomers of warfarin and vitamin K1 metabolism. Br J Clin Pharmacol 22(6):729–732
Christen V, Hickmannb S, Rechenbergb B, Fent K (2010) Highly active human pharmaceuticals in aquatic systems: a concept for their identification based on their mode of action. Aquat Toxicol 96(3):167–181
Cleuvers M (2004) Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicol Environ Saf 59(3):309–315
Cleuvers M (2005) Initial risk assessment for three β-blockers found in the aquatic environment. Chemosphere 59(2):199–205
Cooper MJ, Anders MW (1974) Metabolic and pharmacodynamic interactions of enantiomers of propoxyphene and methorphan. Life Sci 15(9):1665–1672
Cordato DJ, Mather LE, Herkes GK (2003) Stereochemistry in clinical medicine: a neurological perspective. J Clin Neurosci 10(6):649–654
De Andrés F, Castañeda G, Ríos Á (2009) Use of toxicity assays for enantiomeric discrimination of pharmaceutical substances. Chirality 21(8):751–759
Díaz-Cruz MS, García-Galán MJ, Barceló D (2008) Highly sensitive simultaneous determination of sulfonamide antibiotics and one metabolite in environmental waters by liquid chromatography-quadrupole linear ion trap-mass spectrometry. J Chromatogr A 1193(1–2):50–59
Eljarrat E, Guerra P, Barceló D (2008) Enantiomeric determination of chiral persistent organic pollutants and their metabolites. TrAC Trends Anal Chem 27(10):847–861
Farré M, Gros M, Hernández B, Petrovic M, Hancock P, Barceló D (2008) Analysis of biologically active compounds in water by ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 22(1):41–51
Feitosa-Felizzola J, Temime B, Chiron S (2007) Evaluating on-line solid-phase extraction coupled to liquid chromatography-ion trap mass spectrometry for reliable quantification and confirmation of several classes of antibiotics in urban wastewaters. J Chromatogr A 1164(1–2):95–104
Fent K, Weston AA, Caminada D (2006) Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76(2):122–159
Fernández C, González-Doncel M, Pro J, Carbonell G, Tarazona JV (2010) Occurrence of pharmaceutically active compounds in surface waters of the henares-jarama-tajo river system (madrid, spain) and a potential risk characterization. Sci Total Environ 408(3):543–551
Flaherty CM, Dodson SI (2005) Effects of pharmaceuticals on Daphnia survival, growth, and reproduction. Chemosphere 61(2):200–207
Flippin JL, Huggett D, Foran CM (2007) Changes in the timing of reproduction following chronic exposure to ibuprofen in Japanese medaka, Oryzias latipes. Aquat Toxicol 81(1):73–78
Fong PP (1998) Zebra mussel spawning is induced in low concentrations of putative serotonin reuptake inhibitors. Biol Bull 194:143–149
Fong PP, Molnar N (2008) Norfluoxetine induces spawning and parturition in estuarine and freshwater bivalves. Bull Environ Contam Toxicol 81(6):535–538
Fono LJ, Sedlak DL (2005) Use of the chiral pharmaceutical propranolol to identify sewage discharges into surface waters. Environ Sci Technol 39(23):9244–9252
Fono LJ, Kolodziej EP, Sedlak DL (2006) Attenuation of wastewater-derived contaminants in an effluent-dominated river. Environ Sci Technol 40(23):7257–7262
Foran CM, Weston J, Slattery M, Brooks BW, Huggett DB (2004) Reproductive assessment of Japanese medaka (Oryzias latipes) following a four-week fluoxetine (SSRI) exposure. Arch Environ Contam Toxicol 46(4):511–517
Francotte E (2009) Enantioselective chromatography: from its emergence to its successful implementation in the pharmaceutical environment. CHIMIA Int J Chem 63:867–871
Franz PM, Anliker SL, Callaghan JT, DeSante KA, Dhahir PH, Nelson RL, Rubin A (1990) Disposition in humans of racemic picenadol, an opioid analgesic. Drug Metab Dispos 18(6):968–973
Giltrow E, Eccles PD, Hutchinson TH, Sumpter JP, Rand-Weaver M (2011) Characterisation and expression of β1-, β2- and β3-adrenergic receptors in the fathead minnow (Pimephales promelas). Gen Comp Endocrinol 173(3):483–490
Gonçalves RF, Lauretti GR, Mattos AL (2003) Comparative study between 0.5% bupivacaine and 0.5% enantiomeric mixture of bupivacaine (S75–R25) in epidural anesthesia. Rev Bras Anestesiol 53(2):169–176
González S, Petrovic M, Barceló D (2007) Advanced liquid chromatography-mass spectrometry (LC-MS) methods applied to wastewater removal and the fate of surfactants in the environment. TrAC Trends Anal Chem 26(2):116–124
Görög S (2007) The changing face of pharmaceutical analysis. TrAC Trends Anal Chem 26(1):12–17
Gros M, Petrovic M, Barceló D (2006) Development of a multi-residue analytical methodology based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters. Talanta 70(4):678–690
Ha PTT, Hoogmartens J, Van Schepdael A (2006) Recent advances in pharmaceutical applications of chiral capillary electrophoresis. J Pharm Biomed Anal 41(1):1–11
Haginaka J (2008) Recent progresses in protein-based chiral stationary phases for enantioseparations in liquid chromatography. J Chromatogr B 875(1):12–19
Hansen LK, Frost PC, Larson JH, Metcalfe CD (2008) Poor elemental food quality reduces the toxicity of fluoxetine on Daphnia magna. Aquat Toxicol 86(1):99–103
Hashem H, Tründelberg C, Attef O, Jira T (2011) Effect of chromatographic conditions on liquid chromatographic chiral separation of terbutaline and salbutamol on Chirobiotic V column. J Chromatogr A 1218(38):6727–6731
Hashim NH, Nghiem LD, Stuetz RM, Khan SJ (2011) Enantiospecific fate of ibuprofen, ketoprofen and naproxen in a laboratory-scale membrane bioreactor. Water Res 45(18):6249–6258
Heckmann L-H, Callaghan A, Hooper HL, Connon R, Hutchinson TH, Maund SJ, Sibly RM (2007) Chronic toxicity of ibuprofen to Daphnia magna: effects on life history traits and population dynamics. Toxicol Lett 172(3):137–145
Hernández-Borges J, Rodríguez-Delgado MÁ, García-Montelongo FJ, Cifuentes A (2005) Chiral analysis of pollutants and their metabolites by capillary electromigration methods. Electrophoresis 26(20):3799–3813
Hijosa-Valsero M, Matamoros V, Martín-Villacorta J, Bécares E, Bayona JM (2010) Assessment of full-scale natural systems for the removal of PPCPs from wastewater in small communities. Water Res 44(5):1429–1439
Huang YF, Pryor ME, Mather LE, Veering BT (1998) Cardiovascular and central nervous system effects of intravenous levobupivacaine and bupivacaine in sheep. Anesth Analg 86(4):797–804
Huggett DB, Brooks BW, Peterson B, Foran CM, Schlenk D (2002) Toxicity of select beta adrenergic receptor-blocking pharmaceuticals (B-blockers) on aquatic organisms. Arch Environ Contam Toxicol 43(2):229–235
Huggett DB, Khan IA, Foran CM, Schlenk D (2003) Determination of beta-adrenergic receptor blocking pharmaceuticals in United States wastewater effluent. Environ Pollut 121(2):199–205
Hühnerfuss H, Shah MR (2009) Enantioselective chromatography-A powerful tool for the discrimination of biotic and abiotic transformation processes of chiral environmental pollutants. J Chromatogr A 1216(3):481–502
Huq F (2007) Molecular modelling analysis of the metabolism of methadone. Asian J Biochem 2(1):19–30
Hutt AJ (1998) Drug chirality and its pharmacological consequences. In: Smith H, John Williams H (eds) Introduction to the principles of drug design and action, 3rd edn. Elsevier, Amesterdam
Hutt AJ, Valentová J (2003) The chiral switch: the development of single enantiomer drugs from racemates. Acta Fac Pharm Univ Comen 50:7–23
Isidori M, Lavorgna M, Nardelli A, Parrella A, Previtera L, Rubino M (2005) Ecotoxicity of naproxen and its phototransformation products. Sci Total Environ 348(1–3):93–101
Izake EL (2007) Chiral discrimination and enantioselective analysis of drugs: an overview. J Pharm Sci 96(7):1659–1676
Jain AK, Michael R, Ryan JR, McMahon FG (1984) Antihypertensive and biochemical effects of indacrinone enantiomers. Pharmacotherapy 4(5):278–283
Jiang Z, Schurig V (2008) Existence of a low isoenantioselective temperature in complexation gas chromatography: profound change of enantioselectivity of a nickel(II) chiral selector either bonded to, or dissolved in, poly(dimethylsiloxane). J Chromatogr A 1186(1–2):262–270
Johnson DJ, Sanderson H, Brain RA, Wilson CJ, Bestari KT, Solomon KR (2005) Exposure assessment and microcosm fate of selected selective serotonin reuptake inhibitors. Regul Toxicol Pharmacol 42(3):313–323
Jones OAH, Voulvoulis N, Lester JN (2007) The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilising activated sludge treatment. Environ Pollut 145(3):738–744
Kasprzyk-Hordern B, Kondakal VVR, Baker DR (2010) Enantiomeric analysis of drugs of abuse in wastewater by chiral liquid chromatography coupled with tandem mass spectrometry. J Chromatogr A 1217(27):4575–4586
Khetan SK, Collins TJ (2007) Human pharmaceuticals in the aquatic environment: a challenge to green chemisty. Chem Rev 107(6):2319–2364
Kim J-W, Ishibashi H, Yamauchi R, Ichikawa N, Takao Y, Hirano M, Koga M, Arizono K (2009) Acute toxicity of pharmaceutical and personal care products on freshwater crustacean (Thamnocephalus platyurus) and fish (Oryzias latipes). J Toxicol Sci 34(2):227–232
Kot-Wasik A, Debska J, Namiesnik J (2007) Analytical techniques in studies of the environmental fate of pharmaceuticals and personal-care products. TrAC Trends Anal Chem 26(6):557–568
Lamas JP, Salgado-Petinal C, García-Jares C, Llompart M, Cela R, Gómez M (2004) Solid-phase microextraction-gas chromatography-mass spectrometry for the analysis of selective serotonin reuptake inhibitors in environmental water. J Chromatogr A 1046(1–2):241–247
Lämmerhofer M (2010) Chiral recognition by enantioselective liquid chromatography: mechanisms and modern chiral stationary phases. J Chromatogr A 1217(6):814–856
Li L, Zhou S, Jin L, Zhang C, Liu W (2010) Enantiomeric separation of organophosphorus pesticides by high-performance liquid chromatography, gas chromatography and capillary electrophoresis and their applications to environmental fate and toxicity assays. J Chromatogr B 878(17–18):1264–1276
Li Y, Dong F, Liu X, Xu J, Li J, Kong Z, Chen X, Song W, Wang Y, Zheng Y (2011) Simultaneous enantioselective determination of fenbuconazole and its main metabolites in soil and water by chiral liquid chromatography/tandem mass spectrometry. J Chromatogr A 1218(38):6667–6674
Lima VLE (1997) Drugs and chirality: a brief overview. Quim Nova 20(6):657–663
Lister A, Regan C, Van Zwol J, Van Der Kraak G (2009) Inhibition of egg production in zebrafish by fluoxetine and municipal effluents: a mechanistic evaluation. Aquat Toxicol 95(4):320–329
Liu Q-T, Cumming RI, Sharpe AD (2009) Photo-induced environmental depletion processes of β-blockers in river waters. Photochem Photobiol Sci 8(6):768–777
MacLeod SL, Wong CS (2010) Loadings, trends, comparisons, and fate of achiral and chiral pharmaceuticals in wastewaters from urban tertiary and rural aerated lagoon treatments. Water Res 44(2):533–544
MacLeod SL, Sudhir P, Wong CS (2007) Stereoisomer analysis of wastewater-derived β-blockers, selective serotonin re-uptake inhibitors, and salbutamol by high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr A 1170(1–2):23–33
Madureira TV, Barreiro JC, Rocha MJ, Cass QB, Tiritan ME (2009) Pharmaceutical trace analysis in aqueous environmental matrices by liquid chromatography-ion trap tandem mass spectrometry. J Chromatogr A 1216(42):7033–7042
Maftouh M, Granier-Loyaux C, Chavana E, Marini J, Pradines A, Heyden YV, Picard C (2005) Screening approach for chiral separation of pharmaceuticals: part III. Supercritical fluid chromatography for analysis and purification in drug discovery. J Chromatogr A 1088(1–2):67–81
Mannschreck A, Kiesswetter R, von Angerer E (2007) Unequal activities of enantiomers via biological receptors: examples of chiral drug, pesticide, and fragrance molecules. J Chem Educ 84(12):2012–2018
Mascolo G, Balest L, Cassano D, Laera G, Lopez A, Pollice A, Salerno C (2010) Biodegradability of pharmaceutical industrial wastewater and formation of recalcitrant organic compounds during aerobic biological treatment. Bioresour Technol 101(8):2585–2591
Matamoros V, Hijosa M, Bayona JM (2009) Assessment of the pharmaceutical active compounds removal in wastewater treatment systems at enantiomeric level. Ibuprofen and naproxen. Chemosphere 75(2):200–205
Mayer JM, Testa B (1997) Pharmacodynamics, pharmacokinetics and toxicity of ibuprofen enantiomers. Drugs Future 22:1347–1366
Mennigen JA, Harris EA, Chang JP, Moon TW, Trudeau VL (2009) Fluoxetine affects weight gain and expression of feeding peptides in the female goldfish brain. Regul Pept 155(1–3):99–104
Mennigen JA, Sassine J, Trudeau VL, Moon TW (2010) Waterborne fluoxetine disrupts feeding and energy metabolism in the goldfish Carassius auratus. Aquat Toxicol 100(1):128–137
Montanari MLC, Cass QB, Leitão A, Andricopulo AD, Montanari CA (2006) The role of molecular interaction fields on enantioselective and nonselective separation of chiral sulfoxides. J Chromatogr A 1121(1):64–75
Müller TA, Kohler HPE (2004) Chirality of pollutants—effects on metabolism and fate. Appl Microbiol Biotechnol 64(3):300–316
Munoz-Bellido JL, Munoz-Criado S, Garcìa-Rodrìguez JA (2000) Antimicrobial activity of psychotropic drugs: selective serotonin reuptake inhibitors. Int J Antimicrob Agents 14(3):177–180
Nakamura Y, Yamamoto H, Sekizawa J, Kondo T, Hirai N, Tatarazako N (2008) The effects of pH on fluoxetine in Japanese medaka (Oryzias latipes): acute toxicity in fish larvae and bioaccumulation in juvenile fish. Chemosphere 70(5):865–873
Nalecz-Jawecki G (2007) Evaluation of the in vitro biotransformation of fluoxetine with HPLC, mass spectrometry and ecotoxicological tests. Chemosphere 70(1):29–35
Niessen WMA (2003) Progress in liquid chromatography-mass spectrometry instrumentation and its impact on high-throughput screening. J Chromatogr A 1000(1–2):413–436
Nikolai LN, McClure EL, MacLeod SL, Wong CS (2006) Stereoisomer quantification of the -blocker drugs atenolol, metoprolol, and propranolol in wastewaters by chiral high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr A 1131(1–2):103–109
Orlando RM, Cardoso Filho N, Gil ES, Stringhetta JPS (2007) The pharmaceutical importance of chiral drugs. Rev Electrôn Farm IV(1):8–14
Owen SF, Huggett DB, Hutchinson TH, Hetheridge MJ, Kinter LB, Ericson JF, Sumpter JP (2009) Uptake of propranolol, a cardiovascular pharmaceutical, from water into fish plasma and its effects on growth and organ biometry. Aquat Toxicol 93(4):217–224
Paterson G, Metcalfe CD (2008) Uptake and depuration of the anti-depressant fluoxetine by the Japanese medaka (Oryzias latipes). Chemosphere 74(1):125–130
Patrick R, Jan S, Andreas S, Timm K, Burkhard S (2011) First evidence for a stereoselective incorporation of nonylphenol diastereomers in soil-derived organo-clay complexes. Environ Chem Lett 9(2):293–299
Pavlinov SA, Belolipetskaya VG, Piotrovskii VK, Metelitsa VI, Filatova NP, Bochkareva EV (1990) Enantiomers of propranolol in the blood of patients with cardiovascular diseases during long-term therapy. Pharm Chem J 24(1):17–19
Pérez S, Barceló D (2007) Application of advanced MS techniques to analysis and identification of human and microbial metabolites of pharmaceuticals in the aquatic environment. TrAC Trends Anal Chem 26(6):494–514
Pérez S, Barceló D (2008) Applications of LC-MS to quantitation and evaluation of the environmental fate of chiral drugs and their metabolites. TrAC Trends Anal Chem 27(10):836–846
Perrin C, Matthijs N, Mangelings D, Granier-Loyaux C, Maftouh M, Massart DL, Vander Heyden Y (2002a) Screening approach for chiral separation of pharmaceuticals: part II. Reversed-phase liquid chromatography. J Chromatogr A 966(1–2):119–134
Perrin C, Vu VA, Matthijs N, Maftouh M, Massart DL, Vander Heyden Y (2002b) Screening approach for chiral separation of pharmaceuticals: part I. Normal-phase liquid chromatography. J Chromatogr A 947(1):69–83
Pirkle WH, Pochapsky TC (1989) Considerations of chiral recognition relevant to the liquid chromatographic separation of enantiomers. Chem Rev 89(2):347–362
Pirzada Z, Personick M, Biba M, Gong X, Zhou L, Schafer W, Roussel C, Welch CJ (2010) Systematic evaluation of new chiral stationary phases for supercritical fluid chromatography using a standard racemate library. J Chromatogr A 1217(7):1134–1138
Reungoat J, Macova M, Escher BI, Carswell S, Mueller JF, Keller J (2010) Removal of micropollutants and reduction of biological activity in a full scale reclamation plant using ozonation and activated carbon filtration. Water Res 44(2):625–637
Ribeiro AR, Castro PML, Tiritan ME (2012) Environmental fate of chiral pharmaceuticals: determination, degradation and toxicity. In: Lichtfouse E, Schwarzbauer J, Robert D (eds) Environmental chemistry for a sustainable world, vol 2. Springer, Netherlands, pp 3–45. doi:10.1007/978-94-007-2439_1
Rykowska I, Wasiak W (2009) Recent advances in gas chromatography for solid and liquid stationary phases containing metal ions. J Chromatogr A 1216(10):1713–1722
Sánchez-Argüello P, Fernández C, Tarazona JV (2009) Assessing the effects of fluoxetine on Physa acuta (Gastropoda, Pulmonata) and Chironomus riparius (Insecta, Diptera) using a two-species water-sediment test. Sci Total Environ 407(6):1937–1946
Sancho R, Minguillón C (2009) The chromatographic separation of enantiomers through nanoscale design. Chem Soc Rev 38(3):797–805
Santos LHMLM, Araújo AN, Fachini A, Pena A, Delerue-Matos C, Montenegro MCBSM (2010) Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J Hazard Mater 175(1–3):45–95
Schnell S, Kawano A, Porte C, Lee LEJ, Bols NC (2008) Effects of ibuprofen on the viability and proliferation of rainbow trout liver cell lines and potential problems and interactions in effects assessment. Environ Toxicol 24(2):157–165
Schurig V (2001) Separation of enantiomers by gas chromatography. J Chromatogr A 906(1–2):275–299
Scriba GKE (2003) Pharmaceutical and biomedical applications of chiral capillary electrophoresis and capillary electrochromatography: an update. Electrophoresis 24(15):2409–2421
Sipma J, Osuna B, Collado N, Monclús H, Ferrero G, Comas J, Rodriguez-Roda I (2010) Comparison of removal of pharmaceuticals in MBR and activated sludge systems. Desalination 250(2):653–659
Smith SW (2009) Chiral toxicology: it’s the same thing only different. Toxicol Sci 110(1):4–30
Sousa EP, Tiritan ME, Oliveira RV, Afonso CMM, Cass QB, Pinto MMM (2004) Enantiomeric resolution of kielcorin derivatives by HPLC on polysaccharide stationary phases using multimodal elution. Chirality 16(5):279–285
Stanley JK, Ramirez AJ, Chambliss CK, Brooks BW (2007) Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate. Chemosphere 69(1):9–16
Steiner TJ, Ahmed F, Findley LJ, MacGregor EA, Wilkinson M (1998) S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study. Cephalalgia 18(5):283–286
Taylor LT (2009) Supercritical fluid chromatography for the 21st century. J Supercrit Fluids 47(3):566–573
Ternes TA (1998) Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32(11):3245–3260
Trautwein C, Kümmerer K, Metzger JW (2008) Aerobic biodegradability of the calcium channel antagonist verapamil and identification of a microbial dead-end transformation product studied by LC-MS/MS. Chemosphere 72(3):442–450
Trenholm RA, Vanderford BJ, Holady JC, Rexing DJ, Snyder SA (2006) Broad range analysis of endocrine disruptors and pharmaceuticals using gas chromatography and liquid chromatography tandem mass spectrometry. Chemosphere 65(11):1990–1998
Tucker GT (2000) Chiral switches. Lancet 355(9209):1085–1087
Vanderford BJ, Snyder SA (2006) Analysis of pharmaceuticals in water by isotope dilution liquid chromatography/tandem mass spectrometry. Environ Sci Technol 40(23):7312–7320
Westerhoff P, Yoon Y, Snyder S, Wert E (2005) Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ Sci Technol 39(17):6649–6663
Winder VL, Sapozhnikova Y, Pennington PL, Wirth EF (2009) Effects of fluoxetine exposure on serotonin-related activity in the sheepshead minnow (Cyprinodon variegatus) using LC/MS/MS detection and quantitation. Comp Biochem Physiol C Toxicol Pharmacol 149(4):559–565
Winkler M, Lawrence JR, Neu TR (2001) Selective degradation of ibuprofen and clofibric acid in two model river biofilm systems. Water Res 35(13):3197–3205
Winter MJ, Lillicrap AD, Caunter JE, Schaffner C, Alder AC, Ramil M, Ternes TA, Giltrow E, Sumpter JP, Hutchinson TH (2008) Defining the chronic impacts of atenolol on embryo-larval development and reproduction in the fathead minnow (Pimephales promelas). Aquat Toxicol 86(3):361–369
Wistuba D, Schurig V (2000) Enantiomer separation of chiral pharmaceuticals by capillary electrochromatography. J Chromatogr A 875(1–2):255–276
Wong CS, Garrison AW (2000) Enantiomer separation of polychlorinated biphenyl atropisomers and polychlorinated biphenyl retention behavior on modified cyclodextrin capillary gas chromatography columns. J Chromatogr A 866(2):213–220
Zhang H, Spiteller M, Guenther K, Boehmler G, Zuehlke S (2009) Degradation of a chiral nonylphenol isomer in two agricultural soils. Environ Pollut 157(6):1904–1910
Zhang T, Nguyen D, Franco P (2010) Reversed-phase screening strategies for liquid chromatography on polysaccharide-derived chiral stationary phases. J Chromatogr A 1217(7):1048–1055
Acknowledgments
To FCT for PhD grant attributed to Ana Rita Ribeiro (SFRH/BD/64999/2009) and to QREN-POPH, European Social Fund and MCTES. Authors also wish to acknowledge the support from CESPU (09-GCQF-CICS-09) and FCT (FLUOROPHARMA, PTDC/EBB-EBI/111699/2009).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ribeiro, A.R., Castro, P.M.L. & Tiritan, M.E. Chiral pharmaceuticals in the environment. Environ Chem Lett 10, 239–253 (2012). https://doi.org/10.1007/s10311-011-0352-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10311-011-0352-0